股腘动脉粥样硬化：药物洗脱支架能否改善治疗结果？ - Suppr | 超能文献

Femoropopliteal atherosclerosis: do drug-eluting stents improve outcome?

作者信息

Micari Antonio, Nerla Roberto, Cremonesi Alberto

机构信息

Interventional and Endovascular Cardiology, GVM Care and Research, Maria Cecilia Hospital, Ravenna, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e91-e92. doi: 10.2459/JCM.0000000000000593.

DOI:10.2459/JCM.0000000000000593

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Femoropopliteal atherosclerosis: do drug-eluting stents improve outcome?股腘动脉粥样硬化：药物洗脱支架能否改善治疗结果？

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e91-e92. doi: 10.2459/JCM.0000000000000593.

2

Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.紫杉醇洗脱球囊与标准球囊血管成形术治疗股浅动脉和腘动脉支架内再狭窄：PACUBA 试验 1 年结果。

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012.

3

In-stent restenosis management: the best is yet to come.支架内再狭窄的治疗：最好的尚未到来。

J Cardiovasc Surg (Torino). 2017 Aug;58(4):508-517. doi: 10.23736/S0021-9509.17.09953-0. Epub 2017 Mar 20.

4

Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.药物洗脱支架与经皮腔内血管成形术治疗股腘动脉支架内再狭窄：一项回顾性1年多中心研究的结果

J Endovasc Ther. 2016 Aug;23(4):642-7. doi: 10.1177/1526602816642195. Epub 2016 Apr 20.

5

Invagination of an Interwoven Nitinol Stent During Femoropopliteal Placement.股腘动脉置入过程中交织型镍钛诺支架的内翻现象

JACC Cardiovasc Interv. 2020 Apr 27;13(8):e71-e72. doi: 10.1016/j.jcin.2019.11.039. Epub 2020 Jan 29.

6

Risk Factors for Restenosis after Drug-coated Balloon Angioplasty for Complex Femoropopliteal Arterial Occlusive Disease.复杂股腘动脉闭塞性疾病药物涂层球囊血管成形术后再狭窄的危险因素

Ann Vasc Surg. 2019 Feb;55:45-54. doi: 10.1016/j.avsg.2018.06.015. Epub 2018 Aug 15.

7

Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.药物洗脱球囊血管成形术与自膨式编织镍钛诺支架置入术治疗复杂股腘病变患者的比较。

Vascular. 2018 Feb;26(1):54-61. doi: 10.1177/1708538117719580. Epub 2017 Jul 14.

8

Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.紫杉醇洗脱球囊与标准血管成形术治疗股浅动脉和腘动脉近端支架内再狭窄糖尿病患者以降低再狭窄：DEBATE-ISR研究的三年结果

J Endovasc Ther. 2016 Feb;23(1):52-7. doi: 10.1177/1526602815614555. Epub 2015 Oct 28.

9

Device Selection in Femoral-Popliteal Arterial Interventions.股腘动脉介入治疗中的器械选择。

Interv Cardiol Clin. 2020 Apr;9(2):197-206. doi: 10.1016/j.iccl.2019.12.001. Epub 2020 Jan 29.

10

Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.股腘动脉TASC II D型病变的血管内治疗与旁路手术比较：一项单中心研究

Ann Vasc Surg. 2018 Feb;47:179-187. doi: 10.1016/j.avsg.2017.09.008. Epub 2017 Sep 22.

引用本文的文献

1

Up-regulated miR-106b inhibits ox-LDL-induced endothelial cell apoptosis in atherosclerosis.上调的 miR-106b 抑制动脉粥样硬化中 ox-LDL 诱导的内皮细胞凋亡。

Braz J Med Biol Res. 2020 Mar 2;53(3):e8960. doi: 10.1590/1414-431X20198960. eCollection 2020.